Home / Cardiovascular system / Lidocaine
ATC C01BB01 · Antiarrhythmics, Class Ib · updated 4 Nov 2026
Lidocaine shortage
As of 4 Nov 2026, Lidocaine has a reported shortage in 2 of the 16 countries we track (United States, Canada), covering 50 products from 9 companies.
Is there a Lidocaine shortage?
Yes. As of 4 Nov 2026, Lidocaine is reported short in 2 of the 16 countries we track: United States, Canada. The earliest expected return is 15 Jun 2027 (Canada). 49 of 50 affected products have no return date.
Countries2/16
Products50packs or presentations
Companies95 listed
Short since22 Feb 201214.7 years ago
Earliest return15 Jun 2027company estimate
Main reasonNot stated
United States49 products shortCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
United StatesCanada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Fresenius Kabi FRE · Xetra, Pfizer PFE · NYSE, Baxter BAX · NYSE, Aurobindo AUROPHARMA · NSE, Hikma HIK · LSE
Compared with similar medicines
ATC group C01BB · Antiarrhythmics, Class IbAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05) limited | Hospira, Inc., a Pfizer Company | 22 Feb 2012 | not given | Other |
| US | Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05) | Hospira, Inc., a Pfizer Company | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05) | Hospira, Inc., a Pfizer Company | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1) | Amphastar Pharmaceuticals, Inc. | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50) | Anthea Pharma | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Other |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Increased demand Demand increase for the drug |
| US | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) | Fresenius Kabi USA, LLC | 22 Feb 2012 | not given | Not stated |
| US | Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03) | Baxter Healthcare | 25 Oct 2017 | not given | Not stated |
| US | Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02) | Baxter Healthcare | 25 Oct 2017 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74) | Eugia US LLC | 20 Feb 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02) | Eugia US LLC | 20 Feb 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05) | Eugia US LLC | 20 Feb 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30) | Eugia US LLC | 20 Feb 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05) | Eugia US LLC | 20 Feb 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02) | Eugia US LLC | 20 Feb 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10) | Hikma Pharmaceuticals USA, Inc. | 13 Jun 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10) | Eugia US LLC | 13 Jun 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20) | Eugia US LLC | 13 Jun 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10) | Hikma Pharmaceuticals USA, Inc. | 13 Jun 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10) | Eugia US LLC | 13 Jun 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20) | Eugia US LLC | 13 Jun 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50) | Eugia US LLC | 13 Jun 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) | Hikma Pharmaceuticals USA, Inc. | 13 Jun 2018 | not given | Increased demand Demand increase for the drug |
| US | Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) | Hikma Pharmaceuticals USA, Inc. | 13 Jun 2018 | not given | Not stated |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1) | Spectra Medical Devices, LLC | 14 Jun 2018 | not given | Other |
| US | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2) | Huons Co., Ltd. (South Korea) | 14 Jul 2018 | not given | Increased demand Demand increase for the drug |
| CA | LIDOCAINE HYDROCHLORIDE INJECTION USP (10 X5 ML ANSYR) anticipated | PFIZER CANADA ULC | 26 Feb 2027 | 15 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Lidocaine shortage?
Yes. As of 4 Nov 2026, Lidocaine is reported short in 2 of the 16 countries we track: United States, Canada. The earliest expected return is 15 Jun 2027 (Canada). 49 of 50 affected products have no return date.
When will Lidocaine be back in stock?
Companies expect supply back from 15 Jun 2027 in Canada; United States: no date given; Canada: 15 Jun 2027. These are company estimates reported to each authority.
Why is Lidocaine in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Lidocaine shortages?
Fresenius Kabi, Aurobindo, Anthea, Pfizer, Hikma, Baxter, Amphastar, Spectra Medical, Huons South.